Blindness resulting from inflammatory ocular conditions such as age-related macular degeneration (AMD) and progressive keratoconus (PK) is increasing around the world as populations age. Together they affect over 8 million individuals in N. America alone with up to one in four of those over 80 being at risk. Despite this, treatments for such conditions are […]
Read More